GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Pro Medicus PME.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

205.49

+0.18%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2026

Revenue

A$261.7m

FY2017FY2026

Net income

A$265.3m

FY2017FY2026

Free cash flow

A$136.1m

FY2017FY2026

Shareholders' equity

A$450.9m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueA$261.7mA$212.9mA$161.4mA$124.9mA$93.5mA$67.9mA$56.8mA$50.1mA$35.9mA$31.6m
Research and development—A$6.2mA$7.7mA$7.1mA$6.5mA$6.4mA$6.8mA$5.9mA$4.8mA$4.1m
Operating incomeA$196.1mA$157.6mA$112.2mA$83.9mA$62.4mA$42.4mA$30.1mA$25.5mA$14.8mA$14.9m
Net incomeA$265.3mA$115.2mA$82.8mA$60.6mA$44.4mA$30.9mA$23.1mA$19.1mA$10.0mA$9.3m
Diluted earnings per share2.541.100.790.580.420.290.220.180.100.09

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsA$610.1mA$338.7mA$257.4mA$202.1mA$157.1mA$125.6mA$95.6mA$84.3mA$61.0mA$47.2m
Cash and short-term investmentsA$250.6mA$209.2mA$154.9mA$121.5mA$90.6mA$61.8mA$43.4mA$32.3mA$25.2mA$22.8m
Total liabilitiesA$159.2mA$81.7mA$69.7mA$63.4mA$55.3mA$43.9mA$35.5mA$35.0mA$26.0mA$12.4m
Debt—A$2.3mA$2.1mA$1.9mA$2.3mA$2.6mA$2.3m———
Shareholders' equityA$450.9mA$257.0mA$187.7mA$138.8mA$101.7mA$81.7mA$60.2mA$49.3mA$35.1mA$34.8m
Shares outstanding105m105m105m105m105m105m105m104m104m104m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operationsA$136.5mA$111.3mA$86.8mA$62.5mA$61.6mA$38.8mA$31.4mA$24.7mA$13.9mA$14.8m
Capital spending−A$444,000−A$7.4m−A$6.7m−A$6.4m−A$9.0m−A$7.7m−A$7.9m−A$342,000−A$219,000−A$80,000
Free cash flowA$136.1mA$104.0mA$80.1mA$56.1mA$52.6mA$31.1mA$23.5mA$24.3mA$13.7mA$14.7m
Dividends paid−A$64.8m−A$49.1m−A$36.6m−A$26.1m−A$18.8m−A$13.5m−A$10.9m−A$9.8m−A$5.2m−A$3.1m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Mar 2023
RevenueA$136.9mA$124.8mA$115.8mA$97.2mA$87.4mA$74.1mA$68.0mA$34.0m
Operating incomeA$105.5mA$90.7mA$87.8mA$69.9mA$63.3mA$48.9mA$46.7mA$23.4m
Net incomeA$94.1mA$171.2mA$63.5mA$51.7mA$46.5mA$36.3mA$33.5mA$16.7m
Diluted earnings per share0.901.640.610.490.440.350.320.16
Cash from operationsA$67.0mA$69.0mA$66.0mA$52.0mA$55.0mA$31.0mA$21.0mA$21.0m
Capital spending————−A$3.0m−A$3.0m——
Free cash flow————A$52.0mA$28.0m——
Total assetsA$610.1mA$533.9mA$338.7mA$294.2mA$257.4mA$214.1mA$202.1mA$202.1m
Cash and short-term investmentsA$250.6mA$223.6mA$209.2mA$182.3mA$155.4mA$132.5mA$121.5mA$121.5m
DebtA$769,000A$2.5mA$2.3mA$1.8mA$2.1mA$557,000A$1.9m—
Shareholders' equityA$450.9mA$388.9mA$257.0mA$222.3mA$187.7mA$159.2mA$138.8mA$129.1m

Financial ratios

Data as of 2 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin74.9%74.0%69.5%67.2%66.8%62.4%—
Net margin101.4%54.1%51.3%48.6%47.6%45.4%—
Return on equity58.8%44.8%44.1%43.7%43.7%37.8%—
Return on assets43.5%34.0%32.2%30.0%28.3%24.6%—
Free cash flow yield0.8%0.7%0.6%0.4%0.4%0.3%—
Revenue growth22.9%31.9%29.2%33.6%37.7%19.5%—
Earnings growth130.3%39.2%36.5%36.5%44.1%33.7%—
Current ratio6.82x6.49x5.98x5.31x4.46x4.97x—
Debt to equity0.00x0.00x0.00x0.00x0.01x0.01x—
Equity ratio73.9%75.9%72.9%68.7%64.8%65.0%—
Interest coverage—81.45x99.98x217.29x96.13x78.77x6013.20x
R&D as a share of sales—2.9%4.7%5.7%7.0%9.4%12.0%
Buybacks as a share of market value0.0%0.0%0.1%-0.0%0.2%-0.3%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue28.0%31.0%25.3%
Operating income32.7%35.9%35.3%
Net income63.6%53.8%45.2%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin74.5%72.3%71.0%66.7%
Net margin80.2%68.9%65.0%59.3%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings82.0200.6316.2165.5130.2212.3154.8122.0114.097.7
Price to sales83.2108.6162.280.461.996.562.946.631.628.8

Dividends and splits

Per share, in the currency the company pays

Paid for 14 years. Last went ex-dividend on 7 Sept 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year0.370.8860.6710.500.3570.2570.1860.15

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.